tiprankstipranks
Trending News
More News >
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market

Mankind Pharma Ltd. (MANKIND) Income Statement

Compare
1 Followers

Mankind Pharma Ltd. Income Statement

Last quarter (Q4 2025), Mankind Pharma Ltd.'s total revenue was ₹30.79B, an increase of 26.15% from the same quarter last year. In Q4, Mankind Pharma Ltd.'s net income was ₹4.21B. See Mankind Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 122.07B₹ 103.35B₹ 87.43B₹ 77.82B₹ 62.14B
Gross Profit
₹ 87.18B₹ 70.14B₹ 33.88B₹ 53.12B₹ 43.89B
Operating Expenses
₹ 26.92B₹ 29.27B₹ 17.70B₹ 34.33B₹ 27.83B
Depreciation and Amortization
₹ 6.21B₹ 3.98B₹ 3.26B₹ 1.67B₹ 1.19B
EBITDA
₹ 30.18B₹ 28.09B₹ 20.27B₹ 21.47B₹ 18.17B
Operating Income
₹ 60.26B₹ 40.87B₹ 16.18B₹ 19.23B₹ 16.66B
Other Income/Expenses
₹ -35.10B₹ -16.87B₹ 408.39M₹ 988.52M₹ 734.73M
Pretax Income
₹ 25.16B₹ 23.99B₹ 16.59B₹ 19.75B₹ 16.92B
Net Income
₹ 19.91B₹ 19.13B₹ 12.82B₹ 14.33B₹ 12.65B
Per Share Metrics
Basic EPS
₹ 49.17₹ 47.75₹ 32.00₹ 35.78₹ 31.59
Diluted EPS
₹ 49.09₹ 47.68₹ 32.00₹ 35.78₹ 31.59
Weighted Average Shares Outstanding
405.59M 400.59M 400.59M 400.59M 400.59M
Weighted Average Shares Outstanding (Diluted)
404.67M 401.17M 400.59M 400.59M 400.59M
Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis